openPR Logo
Press release

Hyaluronic Acid Injections Market USD 10.5 Billion by 2020

10-26-2016 09:45 AM CET | Health & Medicine

Press release from: iHealthcareAnalyst, Inc.

Hyaluronic Acid Injections Market USD 10.5 Billion by 2020

According to a market research report Hyaluronic Acid Injections Market 2013-2020 published by iHealthcareAnalyst, Inc., the global hyaluronic acid injections market is estimated to reach USD 10.5 Billion in 2020, expanding at a CAGR of 8.8% from 2016 to 2020.

Visit the Hyaluronic Acid Injections Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/hyaluronic-acid-injections-market/

Hyaluronic acid is naturally present in the highest concentrations in fluids in the eyes and joints. The hyaluronic acid for medicine is either extracted from rooster combs or biologically synthesized in bacteria. Hyaluronic acid is used for various joint disorders, including osteoarthritis and during certain eye surgeries including cataract removal, corneal transplantation, and repair of a detached retina and other eye injuries. It is injected into the eye during the procedure to help replace natural fluids. It can be taken by mouth or injected into the affected joint.

The global hyaluronic acid injections market segmentation is based on product types (single-injection cycle products, three-injection cycle products, five- injection cycle products), applications (osteoarthritis, ophthalmic, dermal fillers, vesicoureteral reflux). The global hyaluronic acid injections market report provides market size (Revenue USD Million 2013 to 2020), market share, market trends and forecasts growth trends (CAGR%, 2016 to 2020). The global hyaluronic acid injections market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Injection Type
1.1 Single-Injection Cycle
1.2 Three-Injection Cycle
1.3 Five- Injection Cycle

2. Applications
2.1 Osteoarthritis
2.2 Ophthalmic
2.3 Dermal Fillers
2.4 Vesicoureteral Reflux

3. Geography (Region, Country)
3.1 North America (U.S., Canada)
3.2 Latin America (Brazil, Mexico, Rest of LA)
3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4 Asia Pacific (Japan, China, India, Rest of APAC)
3.5 Rest of the World

4. Company Profiles
4.1 Alcon, Inc.
4.2 Allergan, Inc.
4.3 Anika Therapeutics, Inc.
4.4 F.Hoffmann-La Roche Ltd.
4.5 Ferring Pharmaceuticals, Inc.
4.6 Fidia Farmaceutici SpA
4.7 Galderma S.A.
4.8 Hyaltecg Ltd.
4.9 LifeCore Biomedical LLC
4.10 Meiji Seika Pharma Co. Ltd.
4.11 Merz Aesthetics, Inc.
4.12 Sanofi
4.13 Salix Pharmaceuticals, Inc.
4.14 Seikagaku Corporation
4.15 Shanghai Jingfeng Pharmaceutical Co. Ltd.
4.16 Smith & Nephew plc
4.17 TRB Chemedica International Sa
4.18 Zimmer Holdings, Inc.

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hyaluronic Acid Injections Market USD 10.5 Billion by 2020 here

News-ID: 376413 • Views:

More Releases from iHealthcareAnalyst, Inc.

Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
Global Amyotrophic Lateral Sclerosis Devices Market $19.5 Billion by 2029
The global market for amyotrophic lateral sclerosis devices or motor neuron disease devices anticipated to reach $19.5 billion by 2029, growing at a CAGR of 7.3% over the forecast period, driven by increasing incidence, rising geriatric population, lack of curative treatment, growing public awareness, and technological advancements in palliative care. https://www.ihealthcareanalyst.com/global-amyotrophic-lateral-sclerosis-devices-market/ Amyotrophic lateral sclerosis or Lou Gehrig's disease or motor neuron disease (MND) is characterized by progressive degeneration of the motor nerve
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5.5 Billion by 2025
Global Blood Gas Monitoring Products Market Growing at CAGR of 6.2% to Reach $5. …
The global market for blood gas monitoring products is estimated to reach $5.5 billion by the end of 2025, expanding at a CAGR of 6.2% during the forecast period, supported by growing geriatric population, rising prevalence of chronic diseases, and technological advances. The global blood gas monitoring devices market research report provides market size (Revenue US$ Million 2017 to 2025), market share analysis, growth trends and forecast (CAGR%, 2019 to 2025).
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and Services Market to US$ 73.2 Billion by 2023
Advances in Mobile Connectivity Services to Drive Telemedicine Technologies and …
According to a new market research report Telemedicine Technologies and Services Market 2015-2023 published by iHealthcareAnalyst, Inc., the global computer-aided detection market to reach US$ 73.2 Billion by 2023, expanding at a CAGR of 13.5% from 2018-2023. Visit the Global Telemedicine Technologies and Services Market Analysis and Forecast 2018-2023 report at https://www.ihealthcareanalyst.com/report/telemedicine-technologies-services-market/ The global telemedicine technologies and services market newly published (updated 2018) report estimates the market size (US$ million 2015-2023)
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
Global Internet Pharmacies Market to Cross US$ 100 Billion by 2023
The global internet pharmacies market is estimated to reach US$ 106 Billion by 2023, growing at a CAGR of 15.7% over the forecast period, driven by rising personal disposable income, lower prices, surge in internet penetration, stupendous growth of online retail market and a large number of online players entering the online healthcare product segment. The major players are in a race to increase their share in the industry by

All 5 Releases


More Releases for Injection

Global Light Vehicle Fuel Injection Market Size, Share and Trends Analysis Repor …
The global light vehicle fuel injection market is anticipated to grow at a CAGR of 3.4% during the forecast period (2022-2028). The major factor is the increasing sales of private vehicles across the globe. After COVID-19, people realize they need their personal vehicles to commute from one place to another. The majority of the sales of cars and bikes are happening in emerging economies, and generally, cars having 1200-1500 cc
Injection Molding Materials Market Report 2018: Segmentation by Material (Plasti …
Global Injection Molding Materials market research report provides company profile for ExxonMobil, BASF, Dow, Huntsman, Eastman, INEOS, SABIC, Magna International, Newell Rubbermaid, Beckton Dickinson, IAC group and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Tags---- Gasoline Direct Injection GDI Market, Market Research Report, Industry …
Market Research Reports Search Engine (MRRSE) has recently updated its massive report catalogue by adding a fresh study titled “Global Gasoline Direct Injection (GDI) Market – Analysis, Trends, Growth opportunity and Forecasted during (2018 – 2023)”. This business intelligence study encapsulates vital details about the market current as well as future status during the mentioned forecast period of 2026.The report also targets important facets such as market drivers, challenges, latest
Global Injection Molding Machines Market Analysis 2018-2025 Nissei Plastic Indus …
Recently added detailed market study on "Global Injection Molding Machines Market" examines the performance of the Injection Molding Machines market. It encloses an in-depth Research of the Injection Molding Machines market state and the competitive landscape globally. This report analyzes the potential of Injection Molding Machines market in the present and the future prospects from various angles in detail. The Global Injection Molding Machines Market 2018 report includes Injection Molding Machines
Hyaluronic Acid Products Market (Single-Injection, Three-Injection Cycle and Fiv …
Hyaluronic acid (HA) is a unique non-sulfated glycosaminoglycan, distributed throughout the body in connective tissues, epithelial and neural tissues. Hyaluronic acid contributes significantly to cell proliferation and migration and is observed to be an integral component of the extracellular matrix. Hyaluronic acid has wide number of applications such as orthopedic surgery, rheumatology, ophthalmology, otolaryngology, dermatology and plastic surgery, wound healing and drug delivery. Hyaluronic acid products are segmented on the
Paclitaxel Injection Market driven by advantages of Paclitaxel injection such as …
Paclitaxel injection is a viscous anticancer drug, derived from the bark of the Pacific yew tree. Paclitaxel belongs to the group of drugs called antineoplastic. Paclitaxel injection is primarily used to treat various advanced stage cancer of the breast,ovaries, Kaposi sarcoma and non-small cell lung cancer. It is type of cytoskeletal medication that targets tubulin, which are a type of globular proteins. The body cells that have defects in chromosome